Pembrolizumab (pembro) for Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC): Post Hoc Analyses of Phase 3 KEYNOTE-040 Prior Radiation Treatment (RT) and Disease State.
JOURNAL OF CLINICAL ONCOLOGY（2019）
Key words
Treatment Guidelines
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined